[ad_1]
Zacks Investment Research raised Glanbia's shares (OTCMKTS: GLAPY) of a sales rating to a hold in a report released on Wednesday.
According to Zacks, "Glanbia Plc is engaged in the manufacturing and distribution of dairy and nutritional products and its business segments include Glanbia Performance Nutrition, Global Ingredients, Dairy Ireland and Joint Ventures and Associates. Glanbia segment Performance Nutrition includes high-performance nutritional products under the Optimum Nutrition, BSN, Isopure, Nutramino and ABB brands.The Global Ingredients segment includes American style cheddar cheese, micronutrient premixes and dairy and non-dairy nutritional solutions. Dairy Ireland includes consumer products and agri-food The Joint Ventures and Associates segment covers Glanbia Ingredients Ireland, Glanbia Cheese and Southwest Cheese Glanbia Plc is headquartered in Kilkenny, Ireland. "
L & # 39; GLAPY stock remained steady at $ 91.20 in Wednesday's session. The company has a ratio of 2.01, a ratio of 1.20 and a debt ratio of 0.36. The company has a market capitalization of $ 5.40 billion, a price / earnings ratio of 18.10, a price / earnings ratio of 4.77 and a beta of 0.10. Glanbia has a fifty-two week low of $ 80.23 and a fifty-two week high of $ 98.16.
; "6937718738"; 336; 280; "6345773562,2716359938" +;
Company Profile Glanbia
Glanbia plc is a nutrition company all over the world. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals and Glanbia Ireland Joint Venture. The Glanbia Performance Nutrition segment offers powders, bars and snacks, as well as ready-to-drink beverages through a variety of channels, including specialty retail, the Internet and gyms, as well as food chains. pharmaceutical and mbad-club. Get a free copy of the Zacks Research Report on Glanbia (GLAPY)
For more information on Zacks Investment Research's research opportunities, visit Zacks.com
Source link
